FDA recall record

BYL Solutions Bull Capsules, 1800 mg/grain, 30 count per tin, Hongkong Jiuyuejiu Biology recall — FDA D-0414-2018

Marketed without an Approved NDA/ANDA; product found to be tainted with sildenafil

Class IIIclassification
D-0414-2018official record ID
Feb 21, 2018report date

Recall record at a glance

Official recordD-0414-2018
CategoryDrug Recalls
ClassificationClass III
FDA record statusTerminated
Recalling firmBYL Solutions Inc.
Report dateFeb 21, 2018
Recall initiation dateNov 30, 2017
Quantity329 tins
LocationPalmetto, FL, United States

Official product description

Bull Capsules, 1800 mg/grain, 30 count per tin, Hongkong Jiuyuejiu Biology Technology CO., LTD, BYL Solutions, Inc. dba Nutra Labs, Inc., Palmetto, FL

Why the product was recalled

Marketed without an Approved NDA/ANDA; product found to be tainted with sildenafil

Distribution information

Nationwide

How to read the classification

FDA Class III generally covers situations in which use of or exposure to the product is not likely to cause adverse health consequences. The classification displayed here is taken from the FDA enforcement record.

Additional record details

Recall type: Voluntary: Firm initiated. Initial notification: Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit.

What to do next

If you believe you have the recalled product, use the recall number and firm information above to confirm the official notice and follow the instructions issued by the FDA, recalling firm, retailer or product manufacturer. For drugs and medical devices, decisions about treatment or medical care should be discussed with a qualified health professional.

About this record

Recall Lookup USA preserves the most complete source information successfully retrieved. We do not create missing facts or infer affected lots or VINs. The official record may still change, so use the identifier above when verifying current instructions.

FDA source limitation: openFDA enforcement reports are a reference dataset, not a live public-alert or recall-lifecycle service. FDA notes that enforcement-report status may not be updated after classification. Confirm current actions with the FDA, recalling firm or appropriate healthcare professional when relevant.